Oncomine Comprehensive Panel Oncomine Tumor Mutation Burden MSI
Introduction
The Oncomine Comprehensive Panel Oncomine Tumor Mutation Burden MSI is an advanced genetic test that plays a crucial role in the field of oncology. This test is designed to analyze the genetic mutations present in tumor tissue, enabling healthcare providers to make informed decisions regarding cancer treatment. By understanding the genetic makeup of a tumor, clinicians can tailor therapies to the individual patient, improving outcomes and minimizing side effects.
What the Test Measures
This comprehensive panel assesses two key components:
- Tumor Mutation Burden (TMB): This measures the total number of mutations per megabase of DNA in the tumor. A higher TMB may indicate a better response to immunotherapy.
- Microsatellite Instability (MSI): This detects defects in the DNA mismatch repair system, which can influence treatment options and prognosis.
Who Should Consider This Test
The Oncomine Comprehensive Panel is recommended for patients who exhibit:
- Symptoms of cancer or have been diagnosed with cancer.
- Risk factors such as family history of cancer.
- Those who are considering immunotherapy as a treatment option.
Benefits of Taking the Test
There are several advantages to undergoing the Oncomine Comprehensive Panel:
- Personalized Treatment: Helps identify the most effective treatment options based on the genetic profile of the tumor.
- Informed Decision Making: Provides essential information that can guide treatment decisions.
- Early Detection: Can help in the early detection of genetic predispositions to certain cancers.
Understanding Your Results
Results from the Oncomine Comprehensive Panel will provide insights into the tumor’s genetic characteristics. A higher tumor mutation burden may suggest a potential for response to certain immunotherapies. It is essential to discuss the results with your healthcare provider to understand their implications for treatment.
Test Pricing
| Test Name | Discount Price (KSh) | Regular Price (KSh) |
|---|---|---|
| Oncomine Comprehensive Panel Oncomine Tumor Mutation Burden MSI | 210,000 | 280,000 |
Sample Type and Pre-Test Instructions
The test requires a sample of tumor tissue and peripheral blood. It is important to note that this test must be conducted with a doctor’s prescription, which is not applicable for patients undergoing surgery, those who are pregnant, or individuals planning to travel abroad.
Book Your Test Today
We have branches across Kenya, making it easy for you to access this vital test. To book the Oncomine Comprehensive Panel Oncomine Tumor Mutation Burden MSI, please call or WhatsApp us at +254711564616. Don’t wait—take the first step towards personalized cancer care today!
